PATENT CLAIM ANALYSIS

Application Number: 15927517
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-12
Patent Classification: ["514", "267000"]

Abstract:
The present invention relates to a liquid pharmaceutical composition suitable for administration by inhalation which comprises a diluent and a suspension of particles of 9,10-dimethoxy-2-(2,4,6-trimethylphenylimino)-3-(N-carbamoyl-2-aminoethyl)-3,4,6,7-tetrahydro-2H-pyrimido[6,1-a]isoquinolin-4-one (RPL554) or a pharmaceutically acceptable salt thereof. Also described is a liquid pharmaceutical composition according to the invention for use in the treatment of the human or animal body.

Claim (Index 29):
A liquid pharmaceutical composition according to  claim 28 , wherein the one or more surfactants are selected from one or more non-ionic surfactants.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.4
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15509943', '15549500', '14771109', '14771097', '15614440']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7704155406083214
- 35 USC 102 Novelty (BERT): 0.5521530832508825
- Combined Prediction Score: 0.7485892948725775
- Mean Citation Score: 254.21397800000005
- Max Citation Score: 432.94788
- Similarity Product: 284.7967622023058

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test